Sema4 Holdings Corp. Warrant (SMFRW)
$0.02
$0.00 (0.00%)As on 09-Jan-2023 16:00EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sema4 Holdings Corp. Warrant (SMFRW)
| 26.3 | -41.9 | -90.4 | -96.9 | -- | -- | -- |
|
BSE Sensex*
| -11.5 | -4.6 | 1.3 | -7.6 | 4.0 | 5.1 | 10.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Sema4 Holdings Corp. Warrant (SMFRW)
Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that... delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle, as well as analytics for actionable insights, pre-clinical and clinical trial support, and advanced sequencing services. It also offers Sema4 Signal that enables and advances precision oncology care, from prevention to treatment to remission; and testing for carrier screening, noninvasive prenatal testing, and newborn screening, as well as hereditary cancer testing. In addition, the company provides COVID-19 testing solutions for governmental organizations, K-12 schools, higher education institutions, large businesses, and healthcare providers, as well as residents in Connecticut. Sema4 Holdings Corp. is headquartered in Stamford, Connecticut. Read more
-
Founder, CEO & Director
Dr. Eric E. Schadt Ph.D.
-
Founder, CEO & Director
Dr. Eric E. Schadt Ph.D.
-
Headquarters
Stamford, CT
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Sema4 Holdings Corp. Warrant (SMFRW)
What is the current share price of Sema4 Holdings Corp Warrant (SMFRW) Today?
The share price of Sema4 Holdings Corp Warrant (SMFRW) is $0.02 (NASDAQ) as of 09-Jan-2023 16:00 EDT. Sema4 Holdings Corp Warrant (SMFRW) has given a return of -96.86% in the last 1 years.
What is the current PB & PE ratio of Sema4 Holdings Corp Warrant (SMFRW)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2021 |
-964.44 |
609.79 |
2020 |
0.00 |
0.00 |
2021 |
-964.44 |
609.79 |
2020 |
0.00 |
0.00 |
What is the 52 Week High and Low of Sema4 Holdings Corp Warrant (SMFRW)?
The 52-week high and low of Sema4 Holdings Corp Warrant (SMFRW) are Rs -- and Rs -- as of 10-Sep-2026.
What is the market cap of Sema4 Holdings Corp Warrant (SMFRW)?
Sema4 Holdings Corp Warrant (SMFRW) has a market capitalisation of -- as on 02-Feb-2023. As per SEBI classification, it is a company.
Should I invest in Sema4 Holdings Corp Warrant (SMFRW)?
Before investing in Sema4 Holdings Corp Warrant (SMFRW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.